Broomfield-based Corgenix Medical Corp. and Canadian diagnostic firm Fio Corp. are partnering to combine two of their technologies in a mobile Ebola virus test that could help public health officials better track the spread of the disease.
The companies said Tuesday they are trying to adapt Fio’s Deki Reader, an 8-by-4-inch mobile device that can analyze and transmit data from immunoassays, to Corgenix’s ReEBOV Antigen Rapid Test, a product designed to detect the presence of the Ebola virus in a matter of minutes.
ReEBOV, which received financial backing from the Bill & Melinda Gates Foundation and the Paul G. Allen Family Foundation, recently received the blessings from the World Health Organization and the U.S. Food and Drug Administration for emergency use.
Additional funding from the Allen Family Foundation is helping with the Deki adaptation.
Read more of the article at DailyCamera.com.
